Hayakawa, Yuka
Tsuchiya, Kaoru
Kurosaki, Masayuki
Yasui, Yutaka
Kaneko, Shun
Tanaka, Yuki
Ishido, Shun
Inada, Kento
Kirino, Sakura
Yamashita, Koji
Nobusawa, Tsubasa
Matsumoto, Hiroaki
Kakegawa, Tatsuya
Higuchi, Mayu
Takaura, Kenta
Tanaka, Shohei
Maeyashiki, Chiaki
Tamaki, Nobuharu
Nakanishi, Hiroyuki
Itakura, Jun
Takahashi, Yuka
Asahina, Yasuhiro
Okamoto, Ryuichi
Izumi, Namiki
Article History
Received: 8 August 2021
Accepted: 21 September 2021
First Online: 29 September 2021
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Musashino Red Cross Hospital (No. 28077).
: Informed consent was obtained from all subjects involved in the study.
: Kaoru Tsuchiya, Masayuki Kurosaki, and Namiki Izumi received advisory board fees and honoraria from the speakers’ bureau from Bayer, Eisai, Eli Lilly Japan, and Roche. The Japanese Ministry of Health, Labour and Welfare had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.